Doctor profile · Federal record
Dr. Gayle Balba, M.D.
Infectious Disease Physician (CMS: Infectious Disease) · Washington, DC
- NPI 1073570354
- Accepts Medicare
- MIPS 75.7 / 100 · 2023
- 28 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
3800 Reservoir RD Nw, Kober-Cogan Bld Suite110
Washington, DC 200072113
(202) 687-6845
fax (202) 687-6476
Credentials & registration
- NPI registered
- April 2006 — 20 yrs on file
- Profile last updated
- June 26, 2009
- Year of graduation
- 1998 — 28 yrs since
- Specialty taxonomy
- 207RI0200X — NUCC code
- State license (1)
- District of Columbia #MD31818
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1073570354. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
435
Distinct HCPCS
6
Medicare allowed
$60,037
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99233 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 186 | 69 | $129 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 109 | 66 | $141 | |
99223 |
Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 41 | 40 | $190 | |
99215 |
Established patient office or other outpatient visit, 40-54 minutes | 35 | 32 | $200 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 32 | 24 | $102 | |
99232 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 32 | 23 | $85 |
In context: peer comparison
Among 19 peers in this city , average services per provider: 80. This provider delivers 5.4× the peer median.Medicare Part D · 2023
Top prescriptions
Total claims
295
Patients
0
Total drug cost
$719,916
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Juluca (Dolutegravir/Rilpivirine) | Brand | 38 | 0 | $136,593 |
| Triumeq (Abacavir/Dolutegravir/Lamivudi) | Brand | 25 | 0 | $124,564 |
| Descovy (Emtricitabine/Tenofov Alafenam) | Brand | 24 | 0 | $70,811 |
| Sulfamethoxazole-Trimethoprim (Sulfamethoxazole/Trimethoprim) | Brand | 24 | 0 | $152 |
| Tivicay (Dolutegravir Sodium) | Brand | 23 | 0 | $68,630 |
| Prezcobix (Darunavir/Cobicistat) | Brand | 21 | 0 | $70,931 |
| Biktarvy (Bictegrav/Emtricit/Tenofov Ala) | Brand | 19 | 0 | $78,286 |
| Abacavir-Lamivudine (Abacavir Sulfate/Lamivudine) | Brand | 17 | 0 | $6,994 |
| Entecavir | Generic | 17 | 0 | $13,994 |
| Etravirine | Generic | 16 | 0 | $19,688 |
Hospital affiliations
Frequently asked questions
What is Dr. Gayle Balba's medical specialty?
Dr. Gayle Balba practices Infectious Disease Physician in Washington, DC.
Where does Dr. Gayle Balba practice?
Dr. Gayle Balba practices at 3800 Reservoir RD Nw, Washington, DC 200072113. Office phone: 2026876845.
What is Dr. Gayle Balba's NPI?
Dr. Gayle Balba's National Provider Identifier (NPI) is 1073570354, issued by NPPES.
Does Dr. Gayle Balba accept Medicare assignment?
Yes. Dr. Gayle Balba accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Gayle Balba commonly perform?
Top Medicare-reported procedures in 2023: Subsequent hospital care with moderate levelof medical decision making (HCPCS 99233); Established patient office or other outpatient visit (HCPCS 99214); Initial hospital care with moderate level of medical decision making (HCPCS 99223). Source: CMS Medicare Physician & Other Practitioners file.